Merck acquires Acceleron Pharma for $11.5bn
Merck (MSD) has agreed to buy Acceleron Pharma’s outstanding shares for $180 in cash per share and a total equity…
badania kliniczne
Ryvu Therapeutics has reported a PLN 24.24m net loss from continuing operations
According to a company report, Ryvu Therapeutics recorded a PLN 24.24m standalone net loss from continuing operations in the second…
Google enters life sciences
Google is today not only a huge weapon for the promotion of medicines and pharmaceutical companies, but also a pharmaceutical…
2 billion GSK investments in Poland
GlaxoSmithKline (GSK), for 20 years of its presence, has invested 2 billion PLN in Poland. For example, during this time…
AstraZeneca’s ambitious investment plans
The pharmaceutical concern AstraZeneca wants to invest over PLN 1.5 billion in Poland in the years 2018-2022. The value of…
Celon Pharma ready for clinical trials of a drug for schizophrenia
Polish pharmaceutical company Celon Pharma submitted on 24 August to the Office for Registration of Medicinal Products, Medical Devices and…
